{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:55:08Z","timestamp":1768020908458,"version":"3.49.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05870-4","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:47:31Z","timestamp":1758620851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of phosphatidylinositol (18:1_18:1) in benign prostatic hyperplasia: an integrated study of Mendelian randomization and network pharmacology"],"prefix":"10.1007","volume":"43","author":[{"given":"Bingliang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruilin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"4","key":"5870_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ucl.2009.07.003","volume":"36","author":"W Bushman","year":"2009","unstructured":"Bushman W (2009) Etiology, epidemiology, and natural history of benign prostatic hyperplasia [J]. Urol Clin North Am 36(4):403\u2013415","journal-title":"Urol Clin North Am"},{"issue":"4","key":"5870_CR2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bju.12745","volume":"115","author":"M Speakman","year":"2015","unstructured":"Speakman M, Kirby R, Doyle S et al (2015) Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK [J]. BJU Int 115(4):508\u2013519","journal-title":"BJU Int"},{"issue":"3","key":"5870_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/ijcp.12541","volume":"69","author":"D De Ridder","year":"2015","unstructured":"De Ridder D, Roumegu\u00e8re T, Kaufman L (2015) Urgency and other lower urinary tract symptoms in men aged\u2009\u2265\u200940 years: a Belgian epidemiological survey using the ICIQ-MLUTS questionnaire [J]. Int J Clin Pract 69(3):358\u2013365","journal-title":"Int J Clin Pract"},{"issue":"6","key":"5870_CR4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.urology.2010.01.069","volume":"76","author":"TV Johnson","year":"2010","unstructured":"Johnson TV, Abbasi A, Ehrlich SS et al (2010) Major depression drives severity of American urological association symptom index [J]. Urology 76(6):1317\u20131320","journal-title":"Urology"},{"issue":"4","key":"5870_CR5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1185\/030079908X280473","volume":"24","author":"C Hern\u00e1ndez","year":"2008","unstructured":"Hern\u00e1ndez C, Estivill E, Prieto M et al (2008) Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS\/BPH) [J]. Curr Med Res Opin 24(4):1033\u20131038","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"5870_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","volume":"64","author":"M Oelke","year":"2013","unstructured":"Oelke M, Bachmann A, Descazeaud A et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction [J]. Eur Urol 64(1):118\u2013140","journal-title":"Eur Urol"},{"issue":"3","key":"5870_CR7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eururo.2014.11.006","volume":"68","author":"L Cindolo","year":"2015","unstructured":"Cindolo L, Pirozzi L, Fanizza C et al (2015) Drug adherence and clinical outcomes for patients under Pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study [J]. Eur Urol 68(3):418\u2013425","journal-title":"Eur Urol"},{"key":"5870_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-063014-123902","volume":"67","author":"EH Kim","year":"2016","unstructured":"Kim EH, Larson JA, Andriole GL (2016) Management of benign prostatic hyperplasia [J]. Annu Rev Med 67:137\u2013151","journal-title":"Annu Rev Med"},{"issue":"3","key":"5870_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.pcan.4500221","volume":"1","author":"J Hammarsten","year":"1998","unstructured":"Hammarsten J, H\u00f6gstedt B, Holthuis N et al (1998) Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia [J]. Prostate Cancer Prostatic Dis 1(3):157\u2013162","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"5870_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bju.12728","volume":"115","author":"M Gacci","year":"2015","unstructured":"Gacci M, Corona G, Vignozzi L et al (2015) Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis [J]. BJU Int 115(1):24\u201331","journal-title":"BJU Int"},{"issue":"11","key":"5870_CR11","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.bbalip.2016.08.009","volume":"1861","author":"A Koeberle","year":"2016","unstructured":"Koeberle A, L\u00f6ser K, Th\u00fcrmer M (2016) Stearoyl-CoA desaturase-1 and adaptive stress signaling [J]. Biochim Biophys Acta 1861(11):1719\u20131726","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"5870_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H et al (2017) Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease [J]. Cell 171(2):273\u2013285","journal-title":"Cell"},{"issue":"5600","key":"5870_CR13","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases [J]. Science 298(5600):1911\u20131912","journal-title":"Science"},{"issue":"8","key":"5870_CR14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development [J]. Nat Rev Cancer 9(8):537\u2013549","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"5870_CR15","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-15-0173","volume":"75","author":"A Igea","year":"2015","unstructured":"Igea A, Nebreda AR (2015) The stress kinase p38\u03b1 as a target for cancer therapy [J]. Cancer Res 75(19):3997\u20134002","journal-title":"Cancer Res"},{"issue":"3","key":"5870_CR16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2013.01.029","volume":"152","author":"N Trempolec","year":"2013","unstructured":"Trempolec N, Dave-coll N, Nebreda AR (2013) SnapShot: p38 MAPK signaling [J]. Cell 152(3):656\u2013e1","journal-title":"Cell"},{"issue":"18","key":"5870_CR17","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1073\/pnas.1721441115","volume":"115","author":"GS Kumar","year":"2018","unstructured":"Kumar GS, Clarkson MW, Kunze MBA et al (2018) Dynamic activation and regulation of the mitogen-activated protein kinase p38 [J]. Proc Natl Acad Sci U S A 115(18):4655\u20134660","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5870_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plipres.2012.08.002","volume":"52","author":"L Hodson","year":"2013","unstructured":"Hodson L, Fielding BA (2013) Stearoyl-CoA desaturase: rogue or innocent bystander? [J]. Prog Lipid Res 52(1):15\u201342","journal-title":"Prog Lipid Res"},{"issue":"6","key":"5870_CR19","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","volume":"100","author":"LL Listenberger","year":"2003","unstructured":"Listenberger LL, Han X, Lewis SE et al (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity [J]. Proc Natl Acad Sci U S A 100(6):3077\u20133082","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"5870_CR20","first-page":"6353","volume":"60","author":"S Hardy","year":"2000","unstructured":"Hardy S, Langelier Y, Prentki M (2000) Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects [J]. Cancer Res 60(22):6353\u20136358","journal-title":"Cancer Res"},{"issue":"5","key":"5870_CR21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","volume":"51","author":"G Kramer","year":"2007","unstructured":"Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? [J]. Eur Urol 51(5):1202\u20131216","journal-title":"Eur Urol"},{"issue":"6","key":"5870_CR22","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","volume":"54","author":"JC Nickel","year":"2008","unstructured":"Nickel JC, Roehrborn CG, O\u2019leary M P et al (2008) The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial [J]. Eur Urol 54(6):1379\u20131384","journal-title":"Eur Urol"},{"issue":"1","key":"5870_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pros.10084","volume":"52","author":"G Kramer","year":"2002","unstructured":"Kramer G, Steiner GE, Handisurya A et al (2002) Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation [J]. Prostate 52(1):43\u201358","journal-title":"Prostate"},{"issue":"8","key":"5870_CR24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","volume":"83","author":"GE Steiner","year":"2003","unstructured":"Steiner GE, Stix U, Handisurya A et al (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue [J]. Lab Invest 83(8):1131\u20131146","journal-title":"Lab Invest"},{"key":"5870_CR25","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/nrdp.2016.31","volume":"2","author":"B Chughtai","year":"2016","unstructured":"Chughtai B, Forde JC, Thomas DD et al (2016) Benign prostatic hyperplasia [J]. Nat Rev Dis Primers 2:16031","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"5870_CR26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/pros.22623","volume":"73","author":"L Vignozzi","year":"2013","unstructured":"Vignozzi L, Gacci M, Cellai I et al (2013) Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation [J]. Prostate 73(8):789\u2013800","journal-title":"Prostate"},{"issue":"1","key":"5870_CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12916-023-02881-z","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Liu H, Ye S et al (2023) The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study [J]. BMC Med 21(1):195","journal-title":"BMC Med"},{"key":"5870_CR28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fphar.2019.00743","volume":"10","author":"W Zhang","year":"2019","unstructured":"Zhang W, Huai Y, Miao Z et al (2019) Systems Pharmacology for investigation of the mechanisms of action of traditional Chinese medicine in drug discovery [J]. Front Pharmacol 10:743","journal-title":"Front Pharmacol"},{"issue":"1","key":"5870_CR29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","volume":"26","author":"TT Luo","year":"2020","unstructured":"Luo TT, Lu Y, Yan SK et al (2020) Network Pharmacology in research of Chinese medicine formula: methodology, application and prospective [J]. Chin J Integr Med 26(1):72\u201380","journal-title":"Chin J Integr Med"},{"issue":"1","key":"5870_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12916-023-02894-8","volume":"21","author":"SL Au Yeung","year":"2023","unstructured":"Au Yeung SL, Gill D (2023) Standardizing the reporting of Mendelian randomization studies [J]. BMC Med 21(1):187","journal-title":"BMC Med"},{"issue":"1","key":"5870_CR31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12916-020-01831-3","volume":"18","author":"MK Kwok","year":"2020","unstructured":"Kwok MK, Kawachi I, Rehkopf D et al (2020) The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study [J]. BMC Med 18(1):363","journal-title":"BMC Med"},{"issue":"3","key":"5870_CR32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ (2011) Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants [J]. Int J Epidemiol 40(3):740\u2013752","journal-title":"Int J Epidemiol"},{"issue":"1","key":"5870_CR33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12967-022-03648-5","volume":"20","author":"J Cai","year":"2022","unstructured":"Cai J, Li X, Wu S et al (2022) Assessing the causal association between human blood metabolites and the risk of epilepsy [J]. J Transl Med 20(1):437","journal-title":"J Transl Med"},{"issue":"7","key":"5870_CR34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data [J]. Genet Epidemiol 37(7):658\u2013665","journal-title":"Genet Epidemiol"},{"issue":"5","key":"5870_CR35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B et al (2018) Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases [J]. Nat Genet 50(5):693\u2013698","journal-title":"Nat Genet"},{"issue":"2","key":"5870_CR36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J BOWDEN","year":"2015","unstructured":"BOWDEN J, DAVEY SMITH G BURGESSS (2015) Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression [J]. Int J Epidemiol 44(2):512\u2013525","journal-title":"Int J Epidemiol"},{"issue":"1","key":"5870_CR37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12916-023-02982-9","volume":"21","author":"K Yu","year":"2023","unstructured":"Yu K, Chen XF, Guo J et al (2023) Assessment of bidirectional relationships between brain imaging-derived phenotypes and stroke: a Mendelian randomization study [J]. BMC Med 21(1):271","journal-title":"BMC Med"},{"issue":"D1","key":"5870_CR38","first-page":"D845","volume":"48","author":"J Pi\u00f1ero","year":"2020","unstructured":"Pi\u00f1ero J, Ram\u00edrez-Anguita JM, Sa\u00fcch-Pitarch J et al (2020) The disgenet knowledge platform for disease genomics: 2019 update [J]. Nucleic Acids Res 48(D1):D845\u2013d55","journal-title":"Nucleic Acids Res"},{"key":"5870_CR39","doi-asserted-by":"crossref","unstructured":"Safran M, Dalah I, Alexander J et al (2010) GeneCards Version 3: the human gene integrator [J]. Database (Oxford), 2010: baq020","DOI":"10.1093\/database\/baq020"},{"issue":"D1","key":"5870_CR40","doi-asserted-by":"crossref","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","volume":"50","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhang Y, Lian X et al (2022) Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents [J]. Nucleic Acids Res 50(D1):D1398\u2013d407","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"5870_CR41","doi-asserted-by":"crossref","first-page":"D789","DOI":"10.1093\/nar\/gku1205","volume":"43","author":"JS Amberger","year":"2015","unstructured":"Amberger JS, Bocchini CA, Schiettecatte F et al (2015) OMIM.org: online Mendelian inheritance in man (OMIM\u00ae), an online catalog of human genes and genetic disorders [J]. Nucleic Acids Res 43(Database issue):D789\u2013D798","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5870_CR42","doi-asserted-by":"crossref","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","volume":"47","author":"JS AMBERGER","year":"2019","unstructured":"AMBERGER JS, BOCCHINI C A, SCOTT A F et al (2019) OMIM.org: leveraging knowledge across phenotype-gene relationships [J]. Nucleic Acids Res 47(D1):D1038\u2013d43","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5870_CR43","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets [J]. Nucleic Acids Res 47(D1):D607\u2013d13","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"5870_CR44","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC et al (1984) The development of human benign prostatic hyperplasia with age [J]. J Urol 132(3):474\u2013479","journal-title":"J Urol"},{"issue":"4","key":"5870_CR45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0302-2838(02)00354-8","volume":"42","author":"KM Verhamme","year":"2002","unstructured":"Verhamme KM, Dieleman JP, Bleumink GS et al (2002) Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care\u2013the triumph project [J]. Eur Urol 42(4):323\u2013328","journal-title":"Eur Urol"},{"key":"5870_CR46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jad.2021.09.045","volume":"296","author":"W Zhang","year":"2022","unstructured":"Zhang W, Cao G, Sun Y et al (2022) Depressive symptoms in individuals diagnosed with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS\/BPH) in middle-aged and older Chinese individuals: results from the China health and retirement longitudinal study [J]. J Affect Disord 296:660\u2013666","journal-title":"J Affect Disord"},{"issue":"3","key":"5870_CR47","doi-asserted-by":"crossref","first-page":"e0265060","DOI":"10.1371\/journal.pone.0265060","volume":"17","author":"SU Lee","year":"2022","unstructured":"Lee SU, Lee SH, SO A H et al (2022) Association between benign prostatic hyperplasia and suicide in South korea: A nationwide retrospective cohort study [J]. PLoS ONE 17(3):e0265060","journal-title":"PLoS ONE"},{"issue":"1","key":"5870_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2020.3385","volume":"157","author":"DD Nguyen","year":"2021","unstructured":"Nguyen DD, Marchese M, Cone EB et al (2021) Investigation of suicidality and psychological adverse events in patients treated with finasteride [J]. JAMA Dermatol 157(1):35\u201342","journal-title":"JAMA Dermatol"},{"issue":"12","key":"5870_CR49","doi-asserted-by":"crossref","first-page":"e2248135","DOI":"10.1001\/jamanetworkopen.2022.48135","volume":"5","author":"M Garcia-Argibay","year":"2022","unstructured":"Garcia-Argibay M, Hiyoshi A, Fall K et al (2022) Association of 5\u03b1-Reductase inhibitors with dementia, depression, and suicide [J]. JAMA Netw Open 5(12):e2248135","journal-title":"JAMA Netw Open"},{"issue":"16","key":"5870_CR50","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.108.817619","volume":"119","author":"SH Forsdahl","year":"2009","unstructured":"Forsdahl SH, Singh K, Solberg S et al (2009) Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Troms\u00f8 study, 1994\u20132001 [J]. Circulation 119(16):2202\u20132208","journal-title":"Circulation"},{"issue":"7","key":"5870_CR51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1464-410X.2005.05777.x","volume":"96","author":"AP Berger","year":"2005","unstructured":"Berger AP, Deibl M, Leonhartsberger N et al (2005) Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction [J]. BJU Int 96(7):1073\u20131078","journal-title":"BJU Int"},{"issue":"2","key":"5870_CR52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.urology.2011.09.039","volume":"79","author":"IH Chen","year":"2012","unstructured":"Chen IH, Tsai YS, Tong YC (2012) Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia [J]. Urology 79(2):409\u2013414","journal-title":"Urology"},{"issue":"4","key":"5870_CR53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40618-014-0051-3","volume":"37","author":"L Vignozzi","year":"2014","unstructured":"Vignozzi L, Rastrelli G, Corona G et al (2014) Benign prostatic hyperplasia: a new metabolic disease? [J]. J Endocrinol Invest 37(4):313\u2013322","journal-title":"J Endocrinol Invest"},{"key":"5870_CR54","first-page":"61","volume":"362","author":"D Bridges","year":"2012","unstructured":"Bridges D, Saltiel AR (2012) Phosphoinositides in insulin action and diabetes [J]. Curr Top Microbiol Immunol 362:61\u201385","journal-title":"Curr Top Microbiol Immunol"},{"key":"5870_CR55","doi-asserted-by":"crossref","unstructured":"Dickson EJ (2019) Recent advances in Understanding phosphoinositide signaling in the nervous system [J]. F1000Res, p 8","DOI":"10.12688\/f1000research.16679.1"},{"key":"5870_CR56","first-page":"43","volume":"362","author":"A Ghigo","year":"2012","unstructured":"Ghigo A, Perino A, Hirsch E (2012) Phosphoinositides and cardiovascular diseases [J]. Curr Top Microbiol Immunol 362:43\u201360","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"5870_CR57","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-022-30374-9","volume":"13","author":"M Th\u00fcrmer","year":"2022","unstructured":"Th\u00fcrmer M, Gollowitzer A, Pein H et al (2022) PI(18:1\/18:1) is a SCD1-derived lipokine that limits stress signaling [J]. Nat Commun 13(1):2982","journal-title":"Nat Commun"},{"issue":"Pt 3","key":"5870_CR58","doi-asserted-by":"crossref","first-page":"118970","DOI":"10.1016\/j.jep.2024.118970","volume":"337","author":"H Wang","year":"2025","unstructured":"Wang H, Mu Z, Liang J et al (2025) Hosta plantaginea (Lam.) aschers flower modulates inflammation and amino acid metabolism by inhibiting NF-\u03baB\/MAPK\/JAK-STAT\/PI3K-Akt and AMPK pathways to alleviate benign prostatic hyperplasia in rats [J]. J Ethnopharmacol 337(Pt 3):118970","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"5870_CR59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-023-06362-2","volume":"15","author":"T Yang","year":"2024","unstructured":"Yang T, Chi Y, Wang X et al (2024) PRL-mediated STAT5B\/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling [J]. Cell Death Dis 15(2):128","journal-title":"Cell Death Dis"},{"key":"5870_CR60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jare.2023.04.006","volume":"57","author":"BR Jin","year":"2024","unstructured":"Jin BR, Kim HJ, Na JH et al (2024) Targeting benign prostate hyperplasia treatments: AR\/TGF-\u03b2\/NOX4 Inhibition by Apocynin suppresses inflammation and proliferation [J]. J Adv Res 57:135\u2013147","journal-title":"J Adv Res"},{"key":"5870_CR61","doi-asserted-by":"crossref","first-page":"102816","DOI":"10.1016\/j.redox.2023.102816","volume":"65","author":"BR Jin","year":"2023","unstructured":"Jin BR, Lim CY, Kim HJ et al (2023) Antioxidant mitoquinone suppresses benign prostatic hyperplasia by regulating the AR-NLRP3 pathway [J]. Redox Biol 65:102816","journal-title":"Redox Biol"},{"key":"5870_CR62","doi-asserted-by":"crossref","unstructured":"Chen B, Wang L, Xie R et al (2025) Inflammation-Targeted and antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2\/KEAP1 Multimer Formation and as a Robust Drug Carrier [J]. Adv Healthc Mater, : e2500954","DOI":"10.1002\/adhm.202500954"},{"issue":"6197","key":"5870_CR63","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1126\/science.1255288","volume":"345","author":"M Pinot","year":"2014","unstructured":"Pinot M, Vanni S, Pagnotta S et al (2014) Lipid cell biology. Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins [J]. Science 345(6197):693\u2013697","journal-title":"Science"},{"issue":"2","key":"5870_CR64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX (2001) Untangling the erbb signalling network [J]. Nat Rev Mol Cell Biol 2(2):127\u2013137","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"5870_CR65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc1360","volume":"4","author":"A Gschwind","year":"2004","unstructured":"Gschwind A, Fischer OM, Ullrich A (2004) The discovery of receptor tyrosine kinases: targets for cancer therapy [J]. Nat Rev Cancer 4(5):361\u2013370","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"5870_CR66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/08977190802312844","volume":"26","author":"AW Burgess","year":"2008","unstructured":"Burgess AW (2008) EGFR family: structure physiology signalling and therapeutic targets [J]. Growth Factors 26(5):263\u2013274","journal-title":"Growth Factors"},{"issue":"14","key":"5870_CR67","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2165\/00003495-200767140-00006","volume":"67","author":"MF Press","year":"2007","unstructured":"Press MF, Lenz HJ, EGFR (2007) HER2 and VEGF pathways: validated targets for cancer treatment [J]. Drugs 67(14):2045\u20132075","journal-title":"Drugs"},{"issue":"4","key":"5870_CR68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0960-0760(93)90100-B","volume":"46","author":"C Lubrano","year":"1993","unstructured":"Lubrano C, Toscano V, Petrangeli E et al (1993) Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia [J]. J Steroid Biochem Mol Biol 46(4):463\u2013468","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5870_CR69","doi-asserted-by":"crossref","first-page":"175993","DOI":"10.1016\/j.ejphar.2023.175993","volume":"957","author":"EM Elbaz","year":"2023","unstructured":"Elbaz EM, Darwish A, Gad AM et al (2023) Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b\/EGFR\/EGF and JAK2\/STAT3 signaling pathways through in Silico and in vivo investigations [J]. Eur J Pharmacol 957:175993","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5870_CR70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10787-022-01123-7","volume":"31","author":"ME Abo-El Fetoh","year":"2023","unstructured":"Abo-El Fetoh ME, Abdel-Fattah MM, Mohamed WR et al (2023) Cyclooxygenase-2 activates EGFR-ERK1\/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia [J]. Inflammopharmacology 31(1):499\u2013516","journal-title":"Inflammopharmacology"},{"key":"5870_CR71","doi-asserted-by":"crossref","first-page":"175434","DOI":"10.1016\/j.ejphar.2022.175434","volume":"938","author":"P Wei","year":"2023","unstructured":"Wei P, Lin D, Zhang M et al (2023) Cryptotanshinone modulates proliferation, apoptosis, and fibrosis through inhibiting AR and EGFR\/STAT3 axis to ameliorate benign prostatic hyperplasia progression [J]. Eur J Pharmacol 938:175434","journal-title":"Eur J Pharmacol"},{"key":"5870_CR72","doi-asserted-by":"crossref","unstructured":"Binmahfouz LS, Almukadi H, Alamoudi AJ et al (2022) 6-Paradol Alleviates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Inhibiting AKT\/mTOR Axis [J]. Plants (Basel), 11(19)","DOI":"10.3390\/plants11192602"},{"issue":"3","key":"5870_CR73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/pros.23456","volume":"78","author":"YF Shi","year":"2018","unstructured":"Shi YF, Yu DJ, Jiang CY et al (2018) TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via akt\/mtor signaling [J]. Prostate 78(3):193\u2013201","journal-title":"Prostate"},{"issue":"1","key":"5870_CR74","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12967-023-04432-9","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Zhou Y, Liu D et al (2023) Glutathione peroxidase 3 induced mitochondria-mediated apoptosis via AMPK \/ERK1\/2 pathway and resisted autophagy-related ferroptosis via ampk\/mtor pathway in hyperplastic prostate [J]. J Transl Med 21(1):575","journal-title":"J Transl Med"},{"key":"5870_CR75","doi-asserted-by":"crossref","unstructured":"Chen B, Wang Y, Song G et al (2025) Identification of sinigrin as active compound of rape pollen for treating benign prostatic hyperplasia through PI3K\/AKT\/mTOR axis [J]. Phytother Res","DOI":"10.1002\/ptr.8447"},{"key":"5870_CR76","doi-asserted-by":"crossref","unstructured":"Liu D, Shoag JE, Poliak D et al (2020) Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes [J]. Nat Commun, 11(1): 1987","DOI":"10.1038\/s41467-020-15913-6"},{"issue":"1","key":"5870_CR77","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/s42003-021-02744-4","volume":"4","author":"T Ando","year":"2021","unstructured":"Ando T, Arang N, Wang Z et al (2021) EGFR regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1 [J]. Commun Biol 4(1):1237","journal-title":"Commun Biol"},{"issue":"39","key":"5870_CR78","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/s41388-023-02810-7","volume":"42","author":"K Okamoto","year":"2023","unstructured":"Okamoto K, Ando T, Izumi H et al (2023) AXL activates YAP through the EGFR-LATS1\/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma [J]. Oncogene 42(39):2869\u20132877","journal-title":"Oncogene"},{"issue":"5","key":"5870_CR79","doi-asserted-by":"crossref","first-page":"e2304274","DOI":"10.1002\/advs.202304274","volume":"11","author":"D Lin","year":"2024","unstructured":"Lin D, Luo C, Wei P et al (2024) YAP1 recognizes inflammatory and mechanical cues to exacerbate benign prostatic hyperplasia via promoting cell survival and fibrosis [J]. Adv Sci (Weinh) 11(5):e2304274","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"5870_CR80","doi-asserted-by":"crossref","first-page":"109125","DOI":"10.1016\/j.isci.2024.109125","volume":"27","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li S, Chen S et al (2024) YAP-mediated GPER signaling impedes proliferation and survival of prostate epithelium in benign prostatic hyperplasia [J]. iScience 27(3):109125","journal-title":"iScience"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05870-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:03:42Z","timestamp":1767996222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05870-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5870"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05870-4","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"During the preparation of this work, the authors used GPT 3.5 in order to to improve readability and language. After using this tool\/service, the authors reviewed and edited the content as needed and takes full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"569"}}